Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection

Journal of Hospital Infection

Volumn 79, Issue 3, 2011, Pages 189-193

  Otter, J A ^a   French, G L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibiotics; Community associated MRSA; Infection control; Meticillin resistant Staphylococcus aureus (MRSA); Outbreak; PVL; USA300

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; NEOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; DRUG UTILIZATION; EPIDEMIC; HEALTH CARE ASSOCIATED INFECTION; HEALTH CARE PERSONNEL; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION RISK; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; REVIEW; RISK FACTOR; STAPHYLOCOCCUS INFECTION; SYSTEMATIC REVIEW;

ADULT; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS;

EID: 80053307801     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.04.028     Document Type: Review

References (70)

1. Udo E.E., Pearman J.W., Grubb W.B. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 1993, 25:97-108.
2. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593-598.
3. Enright M.C., Robinson D.A., Randle G., Feil E.J., Grundmann H., Spratt B.G. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002, 99:7687-7692.
4. Deurenberg R.H., Stobberingh E.E. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr Molec Med 2009, 9:100-115.
5. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
6. Otter J.A., French G.L. The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. Clin Microbiol Infect 2008, 14:670-676.
7. Chambers H.F., Deleo F.R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009, 7:629-641.
8. Otter J.A., French G.L. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe. Lancet Infect Dis 2010, 10:227-239.
9. Popovich K.J., Weinstein R.A. Commentary: The graying of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009, 30:9-12.
10. Otter J.A., French G.L. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006, 6:753-755.
11. Boyce J.M. Community-associated methicillin-resistant Staphylococcus aureus as a cause of health care-associated infection. Clin Infect Dis 2008, 46:795-798.
12. Saiman L., O'Keefe M., Graham P.L., et al. Hospital transmission of community-acquired methicillin-resistant Staphylococcus aureus among postpartum women. Clin Infect Dis 2003, 37:1313-1319.
13. Healy C.M., Hulten K.G., Palazzi D.L., Campbell J.R., Baker C.J. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis 2004, 39:1460-1466.
14. Bratu S., Eramo A., Kopec R., et al. Community-associated methicillin-resistant Staphylococcus aureus in hospital nursery and maternity units. Emerg Infect Dis 2005, 11:808-813.
15. Regev-Yochay G., Rubinstein E., Barzilai A., et al. Methicillin-resistant Staphylococcus aureus in neonatal intensive care unit. Emerg Infect Dis 2005, 11:453-456.
16. Linde H., Wagenlehner F., Strommenger B., et al. Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis 2005, 24:419-422.
17. Community-associated methicillin-resistant Staphylococcus aureus infection among healthy newborns - Chicago and Los Angeles County, 2004. Morb Mortal Wkly Rep 2006, 55:329-332. Centers for Disease Control and Prevention.
18. Sax H., Posfay-Barbe K., Harbarth S., et al. Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology. J Hosp Infect 2006, 63:93-100.
19. David M.D., Kearns A.M., Gossain S., Ganner M., Holmes A. Community-associated meticillin-resistant Staphylococcus aureus: nosocomial transmission in a neonatal unit. J Hosp Infect 2006, 64:244-250.
20. Orendi J.M., Coetzee N., Ellington M.J., et al. Community and nosocomial transmission of Panton-Valentine leucocidin-positive community-associated meticillin-resistant Staphylococcus aureus: implications for healthcare. J Hosp Infect 2010, 75:258-264.
21. Saunders A., Panaro L., McGeer A., et al. A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol 2007, 18:128-132.
22. McAdams R.M., Ellis M.W., Trevino S., Rajnik M. Spread of methicillin-resistant Staphylococcus aureus USA300 in a neonatal intensive care unit. Pediatr Int 2008, 50:810-815.
23. Gould I.M., Girvan E.K., Browning R.A., MacKenzie F.M., Edwards G.F. Report of a hospital neonatal unit outbreak of community-associated methicillin-resistant Staphylococcus aureus. Epidemiol Infect 2009, 137:1242-1248.
24. Patrozou E., Reid K., Jefferson J., Mermel L.A. A cluster of community-acquired methicillin-resistant Staphylococcus aureus infections in hospital security guards. Infect Control Hosp Epidemiol 2009, 30:386-388.
25. Maltezou H.C., Vourli S., Katerelos P., et al. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus outbreak among healthcare workers in a long-term care facility. Int J Infect Dis 2009, 13:e401-e406.
26. Teare L., Shelley O.P., Millership S., Kearns A. Outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in a regional burns unit. J Hosp Infect 2010, 76:220-224.
27. Carey A.J., Della-Latta P., Huard R., et al. Changes in the molecular epidemiological characteristics of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2010, 31:613-619.
28. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
29. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
30. Farrington M., Ling J., Ling T., French G.L. Outbreaks of infection with methicillin-resistant Staphylococcus aureus on neonatal and burns units of a new hospital. Epidemiol Infect 1990, 105:215-228.
31. Kumari D.N., Haji T.C., Keer V., Hawkey P.M., Duncanson V., Flower E. Ventilation grilles as a potential source of methicillin-resistant Staphylococcus aureus causing an outbreak in an orthopaedic ward at a district general hospital. J Hosp Infect 1998, 39:127-133.
32. Rampling A., Wiseman S., Davis L., et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2001, 49:109-116.
33. Otter J.A., Klein J.L., Watts T.L., Kearns A.M., French G.L. Identification and control of an outbreak of ciprofloxacin-susceptible EMRSA-15 on a neonatal unit. J Hosp Infect 2007, 67:232-239.
34. Albrich W.C., Harbarth S. Health-care workers: source, vector, or victim of MRSA?. Lancet Infect Dis 2008, 8:289-301.
35. Johnston C.P., Cooper L., Ruby W., Carroll K.C., Cosgrove S.E., Perl T.M. Epidemiology of community-acquired methicillin-resistant Staphylococcus aureus skin infections among healthcare workers in an outpatient clinic. Infect Control Hosp Epidemiol 2006, 27:1133-1136.
36. Kourbatova E.V., Halvosa J.S., King M.D., Ray S.M., White N., Blumberg H.M. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control 2005, 33:385-391.
37. Gonzalez B.E., Rueda A.M., Shelburne S.A., Musher D.M., Hamill R.J., Hulten K.G. Community-associated strains of methicillin-resistant Staphylococcus aureus as the cause of healthcare-associated infection. Infect Control Hosp Epidemiol 2006, 27:1051-1056.
38. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.
39. Davis S.L., Rybak M.J., Amjad M., Kaatz G.W., McKinnon P.S. Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006, 27:1025-1031.
40. King M.D., Humphrey B.J., Wang Y.F., Kourbatova E.V., Ray S.M., Blumberg H.M. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006, 144:309-317.
41. Popovich K., Hota B., Rice T., Aroutcheva A., Weinstein R.A. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2007, 45:2293-2295.
42. Popovich K.J., Weinstein R.A., Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?. Clin Infect Dis 2008, 46:787-794.
43. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
44. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
45. Chini V., Petinaki E., Foka A., Paratiras S., Dimitracopoulos G., Spiliopoulou I. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect 2006, 12:29-34.
46. Larsen A.R., Stegger M., Bocher S., Sorum M., Monnet D.L., Skov R.L. Emergence and characterization of community-associated methicillin-resistant Staphyloccocus aureus infections in Denmark, 1999 to 2006. J Clin Microbiol 2009, 47:73-78.
47. Benoit S.R., Estivariz C., Mogdasy C., et al. Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004. Emerg Infect Dis 2008, 14:1216-1223.
48. Park S.H., Park C., Yoo J.H., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated bloodstream infections in Korea. Infect Control Hosp Epidemiol 2009, 30:146-155.
49. Ben Nejma M., Mastouri M., Bel Hadj Jrad B., Nour M. Characterization of ST80 Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus clone in Tunisia. Diagn Microbiol Infect Dis 2008 Apr 2, [Epub ahead of print].
50. Ramdani-Bouguessa N., Bes M., Meugnier H., et al. Detection of methicillin-resistant Staphylococcus aureus strains resistant to multiple antibiotics and carrying the Panton-Valentine leukocidin genes in an Algiers hospital. Antimicrob Agents Chemother 2006, 50:1083-1085.
51. Antri K., Rouzic N., Dauwalder O., et al. High prevalence of methicillin-resistant Staphylococcus aureus clone ST80-IV in hospital and community settings in Algiers. Clin Microbiol Infect 2011, 17:526-532.
52. D'Agata E.M., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48:274-284.
53. Skov R.L., Jensen K.S. Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections. J Hosp Infect 2009, 73:364-370.
54. Jenkins T.C., McCollister B.D., Sharma R., et al. Epidemiology of healthcare-associated bloodstream infection caused by USA300 strains of methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Infect Control Hosp Epidemiol 2009, 30:233-241.
55. Patel M., Waites K.B., Hoesley C.J., Stamm A.M., Canupp K.C., Moser S.A. Emergence of USA300 MRSA in a tertiary medical centre: implications for epidemiological studies. J Hosp Infect 2008, 68:208-213.
56. Weese J.S., Dick H., Willey B.M., et al. Suspected transmission of methicillin-resistant Staphylococcus aureus between domestic pets and humans in veterinary clinics and in the household. Vet Microbiol 2006, 115:148-155.
57. Huijsdens X.W., van Dijke B.J., Spalburg E., et al. Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob 2006, 5:26.
58. Wulf M.W., Markestein A., van der Linden F.T., Voss A., Klaassen C., Verduin C.M. First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill 2008, 13:8051.
59. Gould I.M. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Int J Antimicrob Agents 2006, 28:379-384.
60. Robinson D.A., Kearns A.M., Holmes A., et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005, 365:1256-1258.
61. Moore C.L., Hingwe A., Donabedian S.M., et al. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. Int J Antimicrob Agents 2009, 34:148-155.
62. Huang H., Flynn N.M., King J.H., Monchaud C., Morita M., Cohen S.H. Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. J Clin Microbiol 2006, 44:2423-2427.
63. Graber C.J., Wong M.K., Carleton H.A., Perdreau-Remington F., Haller B.L., Chambers H.F. Intermediate vancomycin susceptibility in a community-associated MRSA clone. Emerg Infect Dis 2007, 13:491-493.
64. Millar B.C., Loughrey A., Elborn J.S., Moore J.E. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007, 67:109-113.
65. Yang E.S., Tan J., Eells S., Rieg G., Tagudar G., Miller L.G. Body site colonization in patients with community-associated methicillin-resistant Staphylococcus aureus and other types of S. aureus skin infections. Clin Microbiol Infect 2009, 16:425-431.
66. Mertz D., Frei R., Periat N., et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009, 169:172-178.
67. Coia J.E., Duckworth G.J., Edwards D.I., et al. Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect 2006, 63:1-44.
68. Dancer S.J. Considering the introduction of universal MRSA screening. J Hosp Infect 2008, 69:315-320.
69. Otter J.A., French G.L. Community-associated meticillin-resistant Staphylococcus aureus in injecting drug users and the homeless in south London. J Hosp Infect 2008, 69:198-200.
70. Cooke F.J., Gkrania-Klotsas E., Howard J.C., et al. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clin Microbiol Infect 2010, 16:921-926.